NRC Health Common Stock (NRC) is a publicly traded Healthcare sector company. As of May 21, 2026, NRC trades at $19.50 with a market cap of $422.34M and a P/E ratio of 0.38. NRC moved +2.77% today. Year to date, NRC is +2.45%; over the trailing twelve months it is +39.57%. Its 52-week range spans $9.76 to $22.99. Rallies surfaces NRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NRC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NRC recently traded at $19.50. Market cap is $422.34M. P/E ratio is 0.38. Revenue is $137.39M.
| Metric | Value |
|---|---|
| Price | $19.50 |
| Market Cap | $422.34M |
| P/E Ratio | 0.38 |
| EPS | $50.00 |
| Dividend Yield | 0.16% |
| 52-Week High | $22.99 |
| 52-Week Low | $9.76 |
| Volume | 6 |
| Avg Volume | 0 |
| Revenue (TTM) | $137.39M |
| Net Income | $11.60M |
| Gross Margin | 61.88% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $137.39M | $11.60M | $50.00 |
| 2024 | $143.06M | $24.78M | $1.05 |
| 2023 | $148.58M | $30.97M | $1.26 |
| 2022 | $151.57M | $31.80M | $1.28 |
NRC analyst coverage data. Average price target: $0.00.